Sanyuan Biotechnology: Shareholder Luxin Capital reduced its holdings by nearly 6 million shares, bringing its stake down to 0.97%Zhitong·Oct 31, 2025 at 04:26 AM301206+0.99%
Overview of A-share dividends and stock distributions: 18 stocks have their equity registration todayZhitong·Oct 26, 2025 at 06:48 PM002270-0.54%002997+2.88%
Sanyuan Biotechnology released its performance for the first three quarters, with a net profit attributable to the parent company of 67.3987 million yuan, a decrease of 16.80%Zhitong·Oct 26, 2025 at 03:53 AM301206+0.99%
Sanyuan Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 57.4819 million yuan, an increase of 10.73%Zhitong·Aug 28, 2025 at 07:04 AM301206+0.99%
Sanyuan Biotechnology: The company, as a mandatory respondent, is subject to a 450.64% anti-dumping dutyZhitong·Jul 15, 2025 at 02:45 AM301206+0.99%
Sanyuan Biotechnology: The company's production license for allulose is in processZhitong·Jul 9, 2025 at 02:25 AM301206+0.99%
The three major A-share indices collectively fell at the midday break, while the deep-sea technology concept surged36Kr·Jul 1, 2025 at 10:53 PM301206+0.99%300094+0.74%
The United States made a preliminary ruling on the anti-subsidy investigation of erythritolZhitong·May 14, 2025 at 03:01 AM301206+0.99%
Sanyuan Biotechnology: The company is subject to a countervailing duty of 3.49% as a mandatory respondentZhitong·May 14, 2025 at 02:55 AM301206+0.99%
The sugar substitute concept strengthens, Bailong Chuangyuan hits the limit upZhitong·May 9, 2025 at 12:42 AM605016+1.67%600108+2.03%
Sanyuan Biotechnology: Net profit of 24.914 million yuan in the first quarter of 2025, a year-on-year increase of 2.75%Zhitong·Apr 28, 2025 at 09:23 AM301206+0.99%
Synthetic biology concept stocks strengthen, SHENGDA BIO-PHARM hits the daily limit in the afternoonZhitong·Apr 10, 2025 at 01:27 AM603079+0.65%301206+0.99%
Sanyuan Biotechnology: Received corrective measures ordered by the Shandong Securities Regulatory BureauUSHK News·Feb 28, 2025 at 04:54 AM301206+0.99%
Sanyuan Biotechnology shareholder Luxin Capital plans to reduce its holdings by no more than 3%Zhitong·Feb 21, 2025 at 07:15 AM301206+0.99%
